Literature DB >> 34528219

Identification of Optimal Expression Parameters and Purification of a Codon-Optimized Human GLIS1 Transcription Factor from Escherichia coli.

Chandrima Dey1, Vishalini Venkatesan1,2,3, Rajkumar P Thummer4.   

Abstract

GLIS1 has multiple roles in embryonic development and in deriving induced pluripotent stem cells by aiding signaling pathways and chromatin assembly. An inexpensive and simple method to produce human GLIS1 protein from Escherichia coli (E. coli) is demonstrated in this study. Various parameters such as codon usage bias, E. coli strains, media, induction conditions (such as inducer concentration, cell density, time, and temperature), and genetic constructs were investigated to obtain soluble expression of human GLIS1 protein. Using identified expression conditions and an appropriate genetic construct, the human GLIS1 protein was homogeneously purified (purity > 90%) under native conditions. Importantly, the purified protein has upheld a stable secondary structure, as demonstrated by circular dichroism spectroscopy. To the best of our knowledge, this is the first study to report the ideal expression conditions of human GLIS1 protein in E. coli to achieve soluble expression and purification under native conditions, upholding its stable secondary structure post-purification. The biological activity of the purified GLIS1 fusion protein was further assessed in MDA-MB-231 cells. This biologically active human GLIS1 protein potentiates new avenues to understand its molecular mechanisms in different cellular functions in various cancers and in the generation of induced pluripotent stem cells.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Escherichia coli; GLIS1; Heterologous expression; Protein purification; Recombinant protein production; Secondary structure

Mesh:

Substances:

Year:  2021        PMID: 34528219     DOI: 10.1007/s12033-021-00390-z

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  60 in total

1.  Glis1, a unique pro-reprogramming factor, may facilitate clinical applications of iPSC technology.

Authors:  Momoko Maekawa; Shinya Yamanaka
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

2.  Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Aki Sasaki; Masamichi Yamamoto; Michiko Nakamura; Kenta Sutou; Kenji Osafune; Shinya Yamanaka
Journal:  Nat Commun       Date:  2014-04-24       Impact factor: 14.919

3.  The oncogene c-Jun impedes somatic cell reprogramming.

Authors:  Jing Liu; Qingkai Han; Tianran Peng; Meixiu Peng; Bei Wei; Dongwei Li; Xiaoshan Wang; Shengyong Yu; Jiaqi Yang; Shangtao Cao; Kaimeng Huang; Andrew Paul Hutchins; He Liu; Junqi Kuang; Zhiwei Zhou; Jing Chen; Haoyu Wu; Lin Guo; Yongqiang Chen; You Chen; Xuejia Li; Hongling Wu; Baojian Liao; Wei He; Hong Song; Hongjie Yao; Guangjin Pan; Jiekai Chen; Duanqing Pei
Journal:  Nat Cell Biol       Date:  2015-06-22       Impact factor: 28.824

4.  Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1.

Authors:  Momoko Maekawa; Kei Yamaguchi; Tomonori Nakamura; Ran Shibukawa; Ikumi Kodanaka; Tomoko Ichisaka; Yoshifumi Kawamura; Hiromi Mochizuki; Naoki Goshima; Shinya Yamanaka
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

Review 5.  Gli-similar (Glis) Krüppel-like zinc finger proteins: insights into their physiological functions and critical roles in neonatal diabetes and cystic renal disease.

Authors:  Hong Soon Kang; Gary ZeRuth; Kristin Lichti-Kaiser; Shivakumar Vasanth; Zhengyu Yin; Yong-Sik Kim; Anton M Jetten
Journal:  Histol Histopathol       Date:  2010-11       Impact factor: 2.303

6.  A novel gene, GliH1, with homology to the Gli zinc finger domain not required for mouse development.

Authors:  M Nakashima; N Tanese; M Ito; W Auerbach; C Bai; T Furukawa; T Toyono; A Akamine; A L Joyner
Journal:  Mech Dev       Date:  2002-11       Impact factor: 1.882

7.  Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Jdp2-Jhdm1b-Mkk6-Glis1-Nanog-Essrb-Sall4.

Authors:  Bo Wang; Linlin Wu; Dongwei Li; Yuting Liu; Jing Guo; Chen Li; Yuxiang Yao; Yaofeng Wang; Guoqing Zhao; Xiaoshan Wang; Meijun Fu; He Liu; Shangtao Cao; Chuman Wu; Shengyong Yu; Chunhua Zhou; Yue Qin; Junqi Kuang; Jin Ming; Shilong Chu; Xuejie Yang; Ping Zhu; Guangjin Pan; Jiekai Chen; Jing Liu; Duanqing Pei
Journal:  Cell Rep       Date:  2019-06-18       Impact factor: 9.423

8.  Efficient generation of human iPSCs by a synthetic self-replicative RNA.

Authors:  Naohisa Yoshioka; Edwige Gros; Hai-Ri Li; Shantanu Kumar; Dekker C Deacon; Cornelia Maron; Alysson R Muotri; Neil C Chi; Xiang-Dong Fu; Benjamin D Yu; Steven F Dowdy
Journal:  Cell Stem Cell       Date:  2013-08-01       Impact factor: 24.633

Review 9.  GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases.

Authors:  Anton M Jetten
Journal:  Cell Mol Life Sci       Date:  2018-05-19       Impact factor: 9.261

10.  Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells.

Authors:  Linli Wang; Yuehua Chen; Chunyan Guan; Zhiju Zhao; Qiang Li; Jianguo Yang; Jian Mo; Bin Wang; Wei Wu; Xiaohui Yang; Libing Song; Jun Li
Journal:  Stem Cell Res Ther       Date:  2017-11-02       Impact factor: 6.832

View more
  1 in total

1.  Generation of a recombinant version of a biologically active cell-permeant human HAND2 transcription factor from E. coli.

Authors:  Krishna Kumar Haridhasapavalan; Pradeep Kumar Sundaravadivelu; Neha Joshi; Nayan Jyoti Das; Anshuman Mohapatra; Udayashree Voorkara; Vishwas Kaveeshwar; Rajkumar P Thummer
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.